BridgeBio Oncology Therapeutics Inc.
NASDAQ:BBOTBiotechnology
Healthcare
$1.86 -0.39%
-$0.03 today
- Market cap
- $149.27M
- Beta
- 0.29
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$4.95
52W Low $7.00High $14.87
Volume 0.37M
Average 0.37M
Price history
BridgeBio Oncology Therapeutics Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-85.33%
Period high
$13.69
Period low
$1.81
Latest
$1.86
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 13, 2026 | Nov 13, 2026 | |
| 10-Q | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Oct 23, 2026 | Oct 23, 2026 | |
| 4 | Oct 5, 2026 | Oct 5, 2026 | |
| 4 | Oct 5, 2026 | Oct 5, 2026 | |
| 4 | Oct 5, 2026 | Oct 5, 2026 | |
| 4 | Oct 5, 2026 | Oct 5, 2026 | |
| 4 | Sep 14, 2026 | Sep 14, 2026 | |
| EFFECT | Sep 10, 2026 | Sep 11, 2026 | |
| EFFECT | Sep 8, 2026 | Sep 9, 2026 | |
| 8-K | Sep 8, 2026 | Sep 8, 2026 | |
| S-3 | Sep 1, 2026 | Sep 1, 2026 | |
| POS AM | Sep 1, 2026 | Sep 1, 2026 |
Competitors
Who does BridgeBio Oncology Therapeutics Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about BBOT's filings, answered from its disclosures.
What is the latest BBOT filing?
The latest filing shown is SC 13G/A dated Nov 13, 2026.
How many recent filings does BBOT have?
Intrinsic Alpha currently shows 20 recent filings for BBOT.
Continue the stock analysis
Jump to another research area for this company.